Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -22.50 (-9.24%)
Bid:
222.00
Ask:
225.00
Spread: 3.00 (1.351%)
Market Cap: £128.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Director/PDMR Shareholding

14 Apr 2026 09:33

RNS Number : 3874A
MJ Gleeson PLC
14 April 2026
 

14 April 2026

 

MJ Gleeson Plc

("the Company")

 

Notification of Transaction by Directors/PDMRs

 

In accordance with Article 19 of the UK Market Abuse Regulation, the Company was notified on 9 April 2026 that the Directors and Persons Discharging Management Responsibilities ("PDMR") listed below acquired Ordinary shares in the Company in London on 7 April 2026 at a purchase price of £2.57 per Ordinary Share as a result of their participation in the Company's Dividend Re-Investment Plans ("DRIP").

 

Following this transaction:

 

- Stefan Allanson is beneficially interested in 180,694 ordinary shares of £0.02 each;

- Graham Prothero is beneficially interested in 93,032 ordinary shares of £0.02 each; and

- Simon Topliss is beneficially interested in 4,868 ordinary shares of £0.02 each.

This information set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

1.

Details of the issuer or emission allowance market participant

a)

Full name of the entity

MJ Gleeson Plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

2.

Reasons for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the person discharging managerial responsibilities (PDMR) / person closely associated with a PDMR (PCA)

a)

Is this a PDMR or PCA submission?

PDMR

b

First Name

Stefan

b)

Last Name

Allanson

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of instrument

 

Share

b)

Identification Code

GB00BRKD9Z53

c)

Nature of the transaction

Acquisition of Ordinary Shares of £0.02 each pursuant to a Dividend Re-investment Plans ('DRIP')

d)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.57 per share

80 shares

Note: this was a single transaction.

e)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction.

f)

Date of the transaction

 

2026-04-07

 

g)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

1.

Details of the issuer or emission allowance market participant

a)

Full name of the entity

MJ Gleeson Plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

2.

Reasons for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the person discharging managerial responsibilities (PDMR) / person closely associated with a PDMR (PCA)

a)

Is this a PDMR or PCA submission?

PDMR

b

First Name

Graham

b)

Last Name

Prothero

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of instrument

 

Share

b)

Identification Code

GB00BRKD9Z53

c)

Nature of the transaction

Acquisition of Ordinary Shares of £0.02 each pursuant to a Dividend Re-investment Plans ('DRIP')

d)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.57 per share

24 shares

Note: this was a single transaction.

e)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction.

f)

Date of the transaction

 

2026-04-07

 

g)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

1.

Details of the issuer or emission allowance market participant

a)

Full name of the entity

MJ Gleeson Plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

2.

Reasons for the notification

a)

Position / status

Chief Operating Officer (Gleeson Homes)

b)

Initial notification / amendment

Initial notification

3.

Details of the person discharging managerial responsibilities (PDMR) / person closely associated with a PDMR (PCA)

a)

Is this a PDMR or PCA submission?

PDMR

b

First Name

Simon

b)

Last Name

Topliss

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of instrument

 

Share

b)

Identification Code

GB00BRKD9Z53

c)

Nature of the transaction

Acquisition of Ordinary Shares of £0.02 each pursuant to a Dividend Re-investment Plans ('DRIP')

d)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.57 per share

73 shares

Note: this was a single transaction.

e)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction.

f)

Date of the transaction

 

2026-04-07

 

g)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

Enquiries:

 

Leanne Johnson

Company Secretary

MJ Gleeson plc Tel: 01142 612900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHIIMPTMTJBMBF
Date   Source Headline
29th Jan 20217:00 amRNSTotal Voting Rights
11th Jan 20217:00 amRNSNotice of Results & Trading Update
7th Jan 20217:00 amRNSDirector/PDMR Shareholding
31st Dec 20207:00 amRNSTotal Voting Rights
9th Dec 20205:54 pmRNSDirector/PDMR Shareholding
3rd Dec 20201:44 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
30th Nov 20207:00 amRNSTotal Voting Rights
19th Nov 20209:50 amRNSDirector/PDMR Shareholding
10th Nov 20206:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:00 amRNSNotice of AGM
30th Oct 20207:00 amRNSTotal Voting Rights
22nd Oct 20203:01 pmRNSDirector/PDMR Shareholding
9th Oct 20202:25 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSTotal Voting Rights
25th Sep 20209:48 amRNSPerformance Share Plan Award to Directors/PDMRs
16th Sep 202012:46 pmRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSFinal Results
9th Sep 20201:18 pmRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
6th Aug 20205:29 pmRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSTotal Voting Rights
17th Jul 20207:00 amRNSLong Term Incentive Plan Award
9th Jul 20207:00 amRNSTrading Update
8th Jul 20209:42 amRNSDirector/PDMR Shareholding
2nd Jul 202012:07 pmRNSSecond Price Monitoring Extn
2nd Jul 202012:02 pmRNSPrice Monitoring Extension
30th Jun 20207:00 amRNSTotal Voting Rights
15th Jun 20207:00 amRNSTrading Update
9th Jun 202010:29 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
22nd May 20207:00 amRNSCommittee Appointments
18th May 202012:07 pmRNSSecond Price Monitoring Extn
18th May 202012:02 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSReopening of sites and sales offices
7th May 20209:52 amRNSDirector/PDMR Shareholding
30th Apr 20207:00 amRNSTotal Voting Rights
28th Apr 20205:24 pmRNSDisclosure of Rights attached to Listed Securities
28th Apr 20204:42 pmRNSDirector/PDMR Shareholding
9th Apr 20201:32 pmRNSNotification of Transactions by Directors / PCA
8th Apr 20206:14 pmRNSDirector/PDMR Shareholding
8th Apr 20201:16 pmRNSResults of Placing
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSProposed Placing of New Shares
6th Apr 20207:00 amRNSCovid-19 Update
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202012:07 pmRNSSecond Price Monitoring Extn
1st Apr 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.